Early microglial and astrocyte reactivity in preclinical Alzheimer's disease
Alzheimer's & Dementia · 2025-08 · 21 (8)
DOI: 10.1002/alz.70502 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025-08. Verfasst von Marta Fernández-Matarrubia und 19 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Service, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Microglia, Astrocytes. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Research Marqués de Valdecilla (IDIVAL) Foundation.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION The role of neuroinflammation in preclinical Alzheimer's disease (AD) remains unclear. METHODS We assessed changes in microglial and astrocytic biomarkers in a well‐characterized cohort of 211 cognitively unimpaired individuals. Structural equation modeling was used to simultaneously assess all relationships among microglial and astrocytic responses and AD pathological events. RESULTS Plasma glial fibrillary acidic protein (GFAP) and cerebrospinal fluid (CSF) soluble triggering receptor expressed on myeloid cells 2 (sTREM2) were increased in preclinical AD. Plasma GFAP showed an inverse bidirectional relationship with CSF amyloid beta (Aβ)42/40. CSF sTREM2 directly influenced CSF phosphorylated tau‐181 (p‐tau181) and neurogranin, and correlated with CSF S100 calcium‐binding protein beta (S100β). CSF chitinase‐3‐like protein 1 (YKL‐40) mediated the association between CSF p‐tau181 and total tau (t‐tau), whereas CSF S100β and neurofilament light showed mutual influence. DISCUSSION Our findings suggest that microglial and astrocyte reactivity, measured through fluid biomarkers, occur early and impact the amyloid cascade on the preclinical Alzheimer´s continuum. Specifically, GFAP influences amyloid accumulation, sTREM2 promotes tau pathology, and YKL‐40 and S100β contribute to the progression of downstream neurodegenerative changes. Highlights Preclinical Alzheimer's disease (AD) showed increased levels of plasma glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells 2 (sTREM2) compared to cerebrospinal fluid (CSF) in healthy subjects. Higher plasma GFAP levels was directly associated with lower CSF amyloid beta (Aβ)42/Aβ40. Higher CSF sTREM2 concentrations increased CSF phosphorylated tau‐181. Chitinase‐3‐like protein 1 (YKL‐40) mediated tau‐induced neurodegeneration. S100 calcium‐binding protein beta (S100β) was directly linked to higher neurofilament light (NfL) and showed a mutual relationship with sTREM2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Service, Marqués de Valdecilla University Hospital, Santander, Cantabria, Spain.
- Institute for Research Marqués de Valdecilla (IDIVAL), Santander, Cantabria, Spain.
- CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, National Institute of Health Carlos III, Madrid, Spain.
- Immunology Department, Marqués de Valdecilla University Hospital, Santander, Spain.
- Atlantic Fellow for Equity in Brain health, Global Brain Health Institute, University of California, San Francisco, USA.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Marta Fernández-Matarrubia
Förderung
- Institute for Research Marqués de Valdecilla (IDIVAL) Foundation
Zitieren
APA
Fernández-Matarrubia, M., Valera-Barrero, A., Renuncio-García, M., Aguilella, M., Lage, C., López-García, S., Ocejo-Vinyals, J. G., Martínez-Dubarbie, F., Molfetta, G. D., Pozueta-Cantudo, A., García-Martínez, M., Corrales-Pardo, A., Bravo, M., López-Hoyos, M., Irure-Ventura, J., Blennow, K., Ashton, N. J., Zetterberg, H., Sánchez-Juan, P., & Rodríguez-Rodríguez, E. (2025). Early microglial and astrocyte reactivity in preclinical Alzheimer's disease. Alzheimer's & Dementia, 21(8). https://doi.org/10.1002/alz.70502
Vancouver
Fernández-Matarrubia M, Valera-Barrero A, Renuncio-García M, Aguilella M, Lage C, López-García S, et al. Early microglial and astrocyte reactivity in preclinical Alzheimer's disease. Alzheimer's & Dementia. 2025;21(8). doi:10.1002/alz.70502
BibTeX
@article{FernndezMatarrubia2025,
author = {Fernández-Matarrubia, Marta and Valera-Barrero, Andrea and Renuncio-García, Mónica and Aguilella, Marcos and Lage, Carmen and López-García, Sara and Ocejo-Vinyals, J Gonzalo and Martínez-Dubarbie, Francisco and Molfetta, Guglielmo Di and Pozueta-Cantudo, Ana and García-Martínez, María and Corrales-Pardo, Andrea and Bravo, María and López-Hoyos, Marcos and Irure-Ventura, Juan and Blennow, Kaj and Ashton, Nicholas J and Zetterberg, Henrik and Sánchez-Juan, Pascual and Rodríguez-Rodríguez, Eloy},
title = {Early microglial and astrocyte reactivity in preclinical Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {8},
doi = {10.1002/alz.70502}
}
EUVIMED